CY1697A - Novel pharmaceutical use of (NVA)2-cyclosporine - Google Patents

Novel pharmaceutical use of (NVA)2-cyclosporine

Info

Publication number
CY1697A
CY1697A CY169794A CY169794A CY1697A CY 1697 A CY1697 A CY 1697A CY 169794 A CY169794 A CY 169794A CY 169794 A CY169794 A CY 169794A CY 1697 A CY1697 A CY 1697A
Authority
CY
Cyprus
Prior art keywords
nva
cyclosporine
pharmaceutical use
novel pharmaceutical
novel
Prior art date
Application number
CY169794A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848419716A external-priority patent/GB8419716D0/en
Priority claimed from GB848419715A external-priority patent/GB8419715D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CY1697A publication Critical patent/CY1697A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY169794A 1984-08-02 1994-01-14 Novel pharmaceutical use of (NVA)2-cyclosporine CY1697A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848419716A GB8419716D0 (en) 1984-08-02 1984-08-02 Organic compounds
GB848419715A GB8419715D0 (en) 1984-08-02 1984-08-02 Organic compounds

Publications (1)

Publication Number Publication Date
CY1697A true CY1697A (en) 1994-01-14

Family

ID=26288061

Family Applications (1)

Application Number Title Priority Date Filing Date
CY169794A CY1697A (en) 1984-08-02 1994-01-14 Novel pharmaceutical use of (NVA)2-cyclosporine

Country Status (8)

Country Link
EP (2) EP0170623B1 (de)
AU (1) AU581010B2 (de)
CY (1) CY1697A (de)
DE (2) DE3580717D1 (de)
DK (1) DK348385A (de)
HK (1) HK106393A (de)
PH (1) PH21235A (de)
SG (1) SG17993G (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
DE3851152T2 (de) * 1987-09-03 1995-01-26 Univ Georgia Cyclosporin-augenmittel.
ES2033086T3 (es) * 1988-01-29 1993-03-01 Sankyo Company Limited Un procedimiento para la preparacion de una composicion farmaceutica.
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
WO1994023733A1 (de) * 1993-04-20 1994-10-27 Dr. Rentschler Arzneimittel Gmbh & Co. Neue pharmazeutische zubereitungen zur oralen verabreichung enthaltend cyclosporin
DE59510233D1 (de) 1994-11-03 2002-07-11 Novartis Ag Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'－脱氧－3'－氧代－MeBmt]'环孢菌素制备方法
EP0988046B1 (de) 1997-01-30 2004-09-15 Novartis AG Ölfreie pharmazeutische zusammensetzung welche cyclosporin enthält
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
DE10356378A1 (de) * 2003-12-03 2005-06-30 Continental Aktiengesellschaft Verfahren zur Funktionssteuerung eines elektronischen Fahrstabilitätsprogramms für ein Kraftfahrzeug
AU2008304313B2 (en) 2007-09-26 2013-01-10 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
SE448386B (sv) * 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d

Also Published As

Publication number Publication date
SG17993G (en) 1993-04-16
DK348385A (da) 1986-02-03
EP0170623A2 (de) 1986-02-05
AU4563185A (en) 1986-02-06
DK348385D0 (da) 1985-07-31
PH21235A (en) 1987-08-21
DE3526545A1 (de) 1986-02-13
EP0365044A3 (de) 1990-08-22
EP0365044A2 (de) 1990-04-25
DE3580717D1 (de) 1991-01-10
EP0170623A3 (en) 1987-10-28
AU581010B2 (en) 1989-02-09
EP0170623B1 (de) 1990-11-28
HK106393A (en) 1993-10-15

Similar Documents

Publication Publication Date Title
GB2231265B (en) Therapeutic use of serotonin-antagonists
SG17993G (en) Novel pharmaceutical use of(nva)2-cyclosporine
IL75533A (en) Preparation of heteroaryloxyacetamides
GB8507789D0 (en) Preparation of 2-amino-s-triazines
IL80305A0 (en) Preparation of epsilon-butyrolactams
GB8529729D0 (en) Preparation of fish-noodles
AU585890B2 (en) Pharmaceutical use of somatostatin analogues
IL76249A0 (en) Preparation of fluoroformates
IL78379A (en) Preparation of 2-mercaptobenzoxazoles
IL80657A0 (en) Preparation of monochloropinacolone
IL74168A (en) 1alpha-hydroxyvitamin d2 analogs and pharmaceutical compositions containing them
DE3566540D1 (en) Preparation of fluoropyridines
GB8520403D0 (en) Preparation of aminolactone
IL76216A0 (en) Preparation of sulphonylisoureas and-thioureas
GB8422162D0 (en) Preparation of alkyfurans
IL78977A0 (en) Preparation of alkyloxiranes
ZA855872B (en) Novel pharmaceutical use of(nva)2-and dihydro-(val)2-cyclosporins
GB8601724D0 (en) Application of tetracyano-quinodimethanes
GB8708603D0 (en) Preparation of()-13-norfaranal
IL75926A0 (en) Somatostatin analogs and pharmaceutical compositions containing them
DE3566532D1 (en) Preparation of 4-fluorophenols
GB8802972D0 (en) Triperfluoroalkylamines & preparation of same
GB8613066D0 (en) Protection of proteins &c
GB8704561D0 (en) Application of tetrathiafulvalenes
IL91357A0 (en) Pharmaceutical formulations containing certain benzimi-azolylmethyl benzenamides